Antidepressants in oncology: issues and clinical perspectives

被引:6
|
作者
Barriere, Jerome [1 ]
Cherikh, Faredj [2 ]
Pringuey, Dominique
Milano, Gerard [3 ]
Ferrero, Jean-Marc [4 ]
机构
[1] Ctr Antoine Lacassagne, Dept Med Oncol, F-06189 Nice 02, France
[2] CHU Nice, Ctr Antoine Lacassagne, Clin Univ Psychiat, Serv Psychiat Liaison, Nice, France
[3] Ctr Antoine Lacassagne, Serv Oncopharmacol, EA3836, F-06054 Nice, France
[4] Ctr Antoine Lacassagne, Med Oncol Serv, F-06054 Nice, France
关键词
antidepressants; cancer; depression; supportive care; hot flashes; pain;
D O I
10.1684/bdc.2008.0736
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Antidepressants in oncology offer a wide range of applications in everyday supportive care while at. the same time, they are often not well known by oncologists. Several recent studies suggest that depressive disorders have a negative impact on the overall survival in oncology. The care of the depressed patient in oncology would therefore request early detection prior to adapted drug treatment and psychotherapy interventions. This requires better knowledge of antidepressants whose effectiveness has been demonstrated in severe major depression. The use of antidepressants should also he part of the therapeutic armaments in the treatment of pain and hot flushes. However. their effectiveness in improving minor depressive disorders and cancer-related fatigue has not been proved yet.
引用
收藏
页码:1103 / 1111
页数:9
相关论文
共 50 条
  • [41] Imaging biomarkers for clinical applications in neuro-oncology: current status and future perspectives
    Chiu, Fang-Ying
    Yen, Yun
    BIOMARKER RESEARCH, 2023, 11 (01)
  • [42] Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles
    Baumeister, David
    Barnes, Georgina
    Giaroli, Giovanni
    Tracy, Derek
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2014, 4 (04) : 156 - 169
  • [43] Antiapoptotic and neurotrophic effects of antidepressants: A review of clinical and experimental studies
    Drzyzga, Lukasz R.
    Marcinowska, Agnieszka
    Obuchowicz, Ewa
    BRAIN RESEARCH BULLETIN, 2009, 79 (05) : 248 - 257
  • [44] Perspectives of Zambian Clinical Oncology Trainees in the MD Anderson and Zambia Virtual Clinical Research Training Program (MOZART)
    Diao, Kevin
    Kizub, Darya A.
    Ausat, Noveen
    Mwaba, Catherine K.
    Akinfenwa, Chidinma P. Anakwenze
    Cameron, Carrie A.
    Chiao, Elizabeth Y.
    Lombe, Dorothy C.
    Msadabwe, Susan C.
    Lin, Lilie L.
    ONCOLOGIST, 2022, 27 (10): : E804 - E810
  • [45] Exploration of GP perspectives on deprescribing antidepressants: a qualitative study
    Kelly, Dervla
    Graffi, Justin
    Noonan, Maria
    Green, Philip
    McFarland, John
    Hayes, Peter
    Glynn, Liam
    BMJ OPEN, 2021, 11 (04):
  • [46] Potential Targets for the Development of Novel Antidepressants: Future Perspectives
    Thakare, Vishnu N.
    Patel, Bhoomika M.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2015, 14 (02) : 270 - 281
  • [47] Pharmacoeconomic issues in head and neck oncology
    de Souza, Jonas A.
    Lopes, Gilberto de Lima
    Cohen, Ezra E. W.
    CURRENT OPINION IN ONCOLOGY, 2013, 25 (03) : 213 - 217
  • [48] Antidepressants: psychiatrists' opinions and clinical practice
    Depont, F
    Rambelomanana, S
    Le Puil, S
    Begaud, B
    Verdoux, H
    Moore, N
    ACTA PSYCHIATRICA SCANDINAVICA, 2003, 108 (01) : 24 - 31
  • [49] Antidepressants: pharmacological profile and clinical consequences
    Rahola, JG
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2001, 5 : S19 - S28
  • [50] Evidence for Shortening the Duration of Clinical Trials of Antidepressants and a Proposed Paradigm for Such Studies
    Katz, Martin M.
    Berman, Nancy
    Bowden, Charles L.
    Frazer, Alan
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2015, 35 (03) : 329 - 332